MARKET

VBLT

VBLT

VASCULAR
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.995
-0.065
-3.16%
Opening 13:29 02/24 EST
OPEN
2.010
PREV CLOSE
2.060
HIGH
2.100
LOW
1.900
VOLUME
1.98M
TURNOVER
--
52 WEEK HIGH
3.170
52 WEEK LOW
0.9000
MARKET CAP
96.13M
P/E (TTM)
-3.5291
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 23)
Benzinga · 5h ago
CCIV, SNSS, RIOT and EVER among midday movers
Gainers: Yunhong CTI (CTIB) +51%.TimkenSteel (TMST) +42%.Frank's International (FI) +33%.Sunesis Pharmaceuticals (SNSS) +22%.EverQuote (EVER) +14%.China Southern Airlines (ZNH) +14%.The L.S. Starrett (SCX) +14%.Centrais Eletricas Brasileiras (EBR) +11%.Ard...
Seekingalpha · 1d ago
Vascular Biogenics, Sunesis Pharmaceuticals leads healthcare gainers; Isoray, Vaccine among major losers
Gainers: Vascular Biogenics (VBLT) +22%, Sunesis Pharmaceuticals (SNSS) +21%, Savara (SVRA) +8%, Pandion Therapeutics (PAND) +5%.Losers: PAVmed PAVM -17%, Isoray (ISR) -16%, Vaccinex (VCNX) -16%, Onconova Therapeutics ONTX -15%, electroCore (ECOR) -14%.
Seekingalpha · 1d ago
Thinking about buying stock in Vascular Biogenics, Oncolytics Biotech, Protalix Biotherapeutics, AMC Entertainment, or Applied DNA Sciences?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VBLT, ONCY, PLX, AMC, and APDN.
PR Newswire - PRF · 1d ago
VET, TCOM, TTM and ZI among premarket gainers
Yunhong CTI (CTIB) +77%.Dawson Geophysical (DWSN) +39%.ReTo Eco-Solutions (RETO) +31%.Vascular Biogenics (VBLT) +29%.Vinco Ventures (BBIG) +35%.Sunesis Pharmaceuticals (SNSS) +12%.Oncolytics Biotech (ONCY) +11% on encouraging pelareorep + CAR T data in sol...
Seekingalpha · 1d ago
EVER, FIVN, CLMT and API among after-hours movers
Gainers: [[EVER]] +12.3%. [[ZI]] +11.3%. [[FIVN]] +9.3%. [[FREQ]] +8.3%. [[VBLT]] +7.6%.Losers: [[CLMT]] -14.7%. [[XELB]] -10.9%. [[API]] -9.8%. [[ALNY]] -7.9%. [[REAL]] -5.7%.
Seekingalpha · 1d ago
Vascular Biogenics' Ovarian Cancer Gene Therapy Study To Continue, Recommends An Independent Committee
Benzinga · 2d ago
Vascular Biogenics (VBLT) Gets a Buy Rating from JonesTrading
JonesTrading analyst Soumit Roy reiterated a Buy rating on Vascular Biogenics (VBLT) today. The company's shares closed last Monday at $2.65. According to
SmarterAnalyst · 2d ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VBLT. Analyze the recent business situations of VASCULAR through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VBLT stock price target is 4.550 with a high estimate of 5.00 and a low estimate of 3.750.
EPS
Institutional Holdings
Institutions: 39
Institutional Holdings: 2.61M
% Owned: 5.42%
Shares Outstanding: 48.19M
TypeInstitutionsShares
Increased
1
7.69K
New
9
317.53K
Decreased
4
155.23K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+1.16%
Pharmaceuticals & Medical Research
+1.37%
Key Executives
Non-Executive Chairman/Independent Director
Bennett Shapiro
Chief Executive Officer/Director
Dror Harats
Chief Financial Officer/Secretary
Amos Ron
Vice President - Operations
Eyal Breitbart
Vice President
Erez Feige
Vice President
Tami Rachmilewitz
Vice President
Naamit Sher
General Counsel
Ayelet Horn
Non-Executive Independent Director
Ruth Alon
Non-Executive Independent Director
Ruth Arnon
Non-Executive Independent Director
Shmuel Ben Zvi
Non-Executive Independent Director
Ron Cohen
Non-Executive Independent Director
David Hastings
Non-Executive Independent Director
Susan Kelley
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About VBLT
Vascular Biogenics Ltd. is Israel- based late-stage clinical biopharmaceutical company, focused on the discovery, development and commercialization of treatments for cancer. VBL’s clinical pipeline is based on two distinct platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. The Company has developed two programs based on these platforms an oncology program and an anti-inflammatory program. The Company’s lead oncology product VB-111, is a targeted anti-cancer gene-therapy agent that is positioned to potentially treat a wide range of solid tumors. VBL has also developed platform of investigational orally-available small molecules, designated Lecinoxoids, for the treatment of chronic immune-related indications.

Webull offers kinds of Vascular Biogenics Ltd stock information, including NASDAQ:VBLT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VBLT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VBLT stock methods without spending real money on the virtual paper trading platform.